Pharma Executive and Gene Therapy Access Expert, Ramesh Arjunji, PhD, Joins Nanoscope as Executive Vice President, Value and Access [Yahoo! Finance]
Krystal Biotech, Inc. (KRYS)
Last krystal biotech, inc. earnings: 11/4 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.krystalbio.com/investors
Company Research
Source: Yahoo! Finance
retinal diseases and age-related macular degeneration (AMD), today announced that Ramesh Arjunji , PhD, has joined Nanoscope as Executive Vice President of Value and Access. Dr. Arjunji brings a breadth of experience including commercialization, R&D, medical affairs and business development gained from various leadership positions in the biopharmaceutical industry. Nanoscope Therapeutics Logo (PRNewsfoto/Nanoscope Therapeutics) "In addition to his diverse industry experience spanning ophthalmology, neurology, oncology, immunology and medical devices, Ramesh has been an important market access leader for some of the most successfully commercialized gene therapies. We look forward to his contributions as we make preparations to launch MCO-010 as the first restorative treatment for retinitis pigmentosa patients," said Sulagna Bhattacharya , Nanoscope Co-Founder and CEO. "I have had the privilege of guiding multiple gene therapies to market, ensuring they reach the greatest number o
Show less
Read more
Impact Snapshot
Event Time:
KRYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRYS alerts
High impacting Krystal Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
KRYS
News
- Understanding the Genetics of ARCI: Rare but Highly Impactful Skin Disorders [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech to Present at 8th Annual Evercore Healthcare ConferenceGlobeNewswire
KRYS
Earnings
- 11/3/25 - Beat
KRYS
Sec Filings
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- 12/4/25 - Form 144
- KRYS's page on the SEC website